A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00644605

Locations


United States, Alabama
	Pfizer Investigational Site
	Birmingham, Alabama, United States, 35233
	Pfizer Investigational Site
	Birmingham, Alabama, United States, 35294
	Pfizer Investigational Site
	Birmingham, Alabama, United States, 35294-0006

United States, California
	Pfizer Investigational Site
	La Jolla, California, United States, 92037
	Pfizer Investigational Site
	Torrance, California, United States, 90509
	Pfizer Investigational Site
	San Diego, California, United States, 92037
	Pfizer Investigational Site
	Torrance, California, United States, 90502
	Pfizer Investigational Site
	La Jolla, California, United States, 92093
	Pfizer Investigational Site
	Los Angeles, California, United States, 90024
	Pfizer Investigational Site
	Los Angeles, California, United States, 90095
	Pfizer Investigational Site
	Los Angeles, California, United States, 90033

United States, Colorado
	Pfizer Investigational Site
	Aurora, Colorado, United States, 80010
	Pfizer Investigational Site
	Denver, Colorado, United States, 80262

United States, Illinois
	Pfizer Investigational Site
	Chicago, Illinois, United States, 60612

United States, Louisiana
	Pfizer Investigational Site
	Shreveport, Louisiana, United States, 71103

United States, Maryland
	Pfizer Investigational Site
	Baltimore, Maryland, United States, 21205

United States, Massachusetts
	Pfizer Investigational Site
	Boston, Massachusetts, United States, 02111

United States, Michigan
	Pfizer Investigational Site
	ANN ARBOR, Michigan, United States, 48109

United States, Minnesota
	Pfizer Investigational Site
	ROCHESTER, Minnesota, United States, 55905

United States, New York
	Pfizer Investigational Site
	New York, New York, United States, 10032

United States, North Carolina
	Pfizer Investigational Site
	Durham, North Carolina, United States, 27710

United States, Tennessee
	Pfizer Investigational Site
	Nashville, Tennessee, United States, 37232

United States, Texas
	Pfizer Investigational Site
	Houston, Texas, United States, 77030

United States, Wisconsin
	Pfizer Investigational Site
	Milwaukee, Wisconsin, United States, 53215

Australia, New South Wales
	Pfizer Investigational Site
	DARLINGHURST, New South Wales, Australia, 2010

Australia, Victoria
	Pfizer Investigational Site
	Melbourne, Victoria, Australia, 3004

Belgium
	Pfizer Investigational Site
	Bruxelles, Belgium, 1070
	Pfizer Investigational Site
	Leuven, Belgium, 3000

Brazil, SP
	Pfizer Investigational Site
	Sao Paulo, SP, Brazil, 05403-900

Czech Republic
	Pfizer Investigational Site
	Prague 4, Czech Republic, 140 00
	Pfizer Investigational Site
	Prague 4, Czech Republic, 140 21

Denmark
	Pfizer Investigational Site
	Kobenhavn, Denmark, 2100

France
	Pfizer Investigational Site
	CLAMART, France, 92141

Germany
	Pfizer Investigational Site
	Giessen, Germany, 35385
	Pfizer Investigational Site
	Giessen, Germany, 35392
	Pfizer Investigational Site
	Berlin, Germany, 13353
	Pfizer Investigational Site
	Leipzig, Germany, 04103
	Pfizer Investigational Site
	Hannover, Germany, 30625

Hong Kong
	Pfizer Investigational Site
	Shatin N T, Hong Kong

Hungary, Pest
	Pfizer Investigational Site
	Budapest, Pest, Hungary, 1529

Hungary, Zala
	Pfizer Investigational Site
	Zalaegerszeg, Zala, Hungary, 8900

Israel
	Pfizer Investigational Site
	Tel Hashomer, Israel, 52621
	Pfizer Investigational Site
	Petach Tikva, Israel, 49100

Italy
	Pfizer Investigational Site
	Bologna, Italy, 40138
	Pfizer Investigational Site
	Pisa, Italy, 56126
	Pfizer Investigational Site
	Pisa, Italy, 56124

Korea, Republic of
	Pfizer Investigational Site
	Suwon, Korea, Republic of, 442-721

Malaysia
	Pfizer Investigational Site
	Kuala Lumpur, Malaysia, 59100

Mexico
	Pfizer Investigational Site
	Tlalpan, Mexico

Netherlands
	Pfizer Investigational Site
	Amsterdam, Netherlands, 1081 HV

Norway
	Pfizer Investigational Site
	Oslo, Norway, NO-0027

Poland
	Pfizer Investigational Site
	Katowice, Poland, 40-057
	Pfizer Investigational Site
	Zabrze, Poland, 41-800
	Pfizer Investigational Site
	Warszawa, Poland, 01-138
	Pfizer Investigational Site
	Warszawa, Poland, 03-709

Singapore
	Pfizer Investigational Site
	Singapore, Singapore, 168752

South Africa
	Pfizer Investigational Site
	Johannesburg, South Africa, 2193
	Pfizer Investigational Site
	Cape Town, South Africa, 7700

South Africa, 7500
	Pfizer Investigational Site
	Parow, 7500, South Africa

Spain
	Pfizer Investigational Site
	Madrid, Spain, 28041
	Pfizer Investigational Site
	Barcelona, Spain, 08036
	Pfizer Investigational Site
	Barcelona, Spain, 08035

Sweden
	Pfizer Investigational Site
	Goteborg, Sweden, 413 45
	Pfizer Investigational Site
	Molndal, Sweden, 431 80

United Kingdom
	Pfizer Investigational Site
	HIGH HEATON, NEWCASTLE-UPON-TYNE, United Kingdom, NE7 7DW
	Pfizer Investigational Site
	GLASGOW, United Kingdom, G11 6NT

United Kingdom, Cambridgeshire
	Pfizer Investigational Site
	Papworth Everard, Cambridgeshire, United Kingdom, CB3 8RE

United Kingdom, South Yorkshire
	Pfizer Investigational Site
	Sheffield, South Yorkshire, United Kingdom, S10 2JF

Sponsors and Collaborators

Pfizer

Investigators


Study Director:	Pfizer CT.gov Call Center	Pfizer